ALLMedicine™ Thyroid Disorders Center

Nov 19th, 2021 - Metabolic disorders and cardiovascular disease threaten human health. Many studies have assessed the phenomenon of metabolic disorders and cardiovascular disease in patients with diabetes. However, in euglycemic individuals, the relationships betw...

Nov 12th, 2021 - Acute suppurative thyroiditis (AST) is a rare but potentially life-threatening thyroid disease with a high mortality if left untreated. Thus, differentiation from other thyroid disorders is highly important in clinical practice. A 22-year-old male...

Nov 12th, 2021 - Patients with thyroid function abnormalities (hyperthyroidism, hypothyroidism) are studied and treated in this protocol. Patients undergo routine history and physical examination, standard endocrine blood and urine tests, a standard TRH test, thyr...

Nov 12th, 2021 - Longitudinal studies have investigated the effects of changing iodine status on thyroid disorders, but the effect of a transition from more than adequate iodine to adequate iodine on national changes in prevalence adjusted for changing risk factor...

Nov 6th, 2021 - Thyroid abnormalities are well reported following childhood treatment for Hodgkin Lymphoma (HL). Limited information exists for adult patients and after modern treatments. We analyzed risks of thyroid disorders in 237 female participants treated a...

Feb 23rd, 2020 - The aim of this study was to develop evidence-based recommendations for safe, effective and appropriate thyroidectomy. Surgical management of thyroid disease has evolved considerably over several decades leading to variability in rendered care. Ov...

Feb 23rd, 2020 - To develop evidence-based recommendations for safe, effective, and appropriate thyroidectomy. Surgical management of thyroid disease has evolved considerably over several decades leading to variability in rendered care. Over 100,000 thyroid operat...

Jul 14th, 2010 - The purpose of the present guidelines on the (131)I therapy of benign thyroid disorders formulated by the European Association of Nuclear Medicine (EANM) Therapy Committee is to provide advice to nuclear medicine clinicians on how to treat benign ...

Nov 12th, 2021 - Patients with thyroid function abnormalities (hyperthyroidism, hypothyroidism) are studied and treated in this protocol. Patients undergo routine history and physical examination, standard endocrine blood and urine tests, a standard TRH test, thyr...

Aug 16th, 2021 - Thyroid disorders are most commonly concomitant with prematurity and still remains a controversial topic. Preterm infants are susceptible to thyroid disorders due to many reasons including immaturity of hypothalamopituitary-thyroid axis, non-thyro...

Mar 10th, 2021 - Pregnant women with chronic disease such as epilepsy, sclerosis, hypertension, and thyroid disorders have a significant increased risk of pregnancy complications such as spontaneous abortion, preterm delivery, and caesarian section. Children born ...

Dec 28th, 2020 - Total thyroidectomy, rather thyroidectomy, is currently widely accepted as the modality of choice for treatment of benign thyroid disorders that require surgical excision. The goal of post-thyroidectomy management is to reach a "safe physiological...

Nov 19th, 2020 - The Covid-19 pandemic has impacted healthcare workers physically and psychologically. Healthcare workers have ben required to work under stressful conditions and take difficult decisions involving ethical implications. Increasing work demands on h...

Oct 7th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr David Lui Treatment of COVID-19 with interferon beta-1b — even for just a few days, a much shorter period than is commonly used for maintenance...

Aug 17th, 2021 - Rates of autoimmune diseases, including thyroid disorders and multiple sclerosis (MS), are higher among families of patients with pediatric MS compared with unaffected families, new research suggests. This finding "reinforces the fact that there a...

Dec 20th, 2020 - Dung T. Le, MD Treatment with the anti-PD-1 agent pembrolizumab produced an objective response rate (ORR) of 47% in a phase II trial of patients with noncolorectal GI cancers whose tumors were mismatch repair-deficient, reported Dung T. Le, MD, d...

Dec 20th, 2020 - Craig H. Moskowitz, MD Treatment with the PD-1 inhibitor pembrolizumab (Keytruda) generated responses in 66% of patients with heavily pretreated classical Hodgkin lymphoma (cHL), according to preliminary results of a phase IB study reported at th...

Sep 23rd, 2020 - There is no evidence to support the idea that previous autoimmunity before or after alemtuzumab treatment predicts subsequent rare but serious and possibly life-threatening autoimmune events that have recently been linked to the drug, a new study ...